chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Patient with 2 COVID vaccines who admitted with hypoxia and COVID detected test.  Provider d/c note:  ""87-year-old male patient with past medical history of chronic obstructive pulmonary disease, chronic kidney disease stage IIIB, hypertension, diastolic CHF, coronary artery disease, status post CABG status post stenting, presents with increasing shortness of breath, cough with yellowish expectoration and some chest pain.  He was found to be COVID positive, viral respiratory panel was negative for everything else.  CTA chest showed increased bronchial wall thickening and peribronchial nodularity and consolidation.  He was also found to have COPD exacerbation and started on appropriate therapy.  Respiratory status improved and he was weaned off of oxygen.  He did desaturate with ambulation so he was sent home with oxygen.  Pt was stable on discharge.     Acute hypoxic respiratory failure 2/2 COPD exacerbation, CAP and COVID  - hypoxia resolved - CTA chest showed increased bronchial wall thickening and peribronchial nodularity and consolidation  - treated with a 5 day course of ceftriaxone and prednisone  - continue Breztri and Trelegy"
Age: 35.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 1 patient vaccinated with Pfizer lot FC3183 beyond best use date
Age: 12.0
Sex: F
Vaccine: IPV
Symptoms: Wrong product administered
Clinical narrative: Patient was due for a TB test and received 0.1 mL of the IPV instead of TB. The patient was given the correct dosage of TB afterward.
Age: 66.0
Sex: U
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: 16 patients vaccinated with Pfizer lot FF8841
Age: 101.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacillus test positive, Bacterial infection, Bacteroides test positive, Blood culture positive, COVID-19
Clinical narrative: Patient with 2 COVID vaccines who admitted with mild COVID symptoms with concerns for bacteremia.  Provider d/c note:  "Well preserved vaccinated 103 year old residing with her daughter who recently was infected with COVID presents with episode of encephalopathy and apparent syncope.  Testing revealed COVID detected but patient appeared well.  Patient released home but then monitoring blood cultures reported positive for Gram positive rods.  Patient admitted for IV antibiotics but patients culture then interpreted as pseudobacteremia due to Bacillus species.  Patient continued to appear well and without complaints, fever, hypoxemia or pain and was slated to be discharged home but the positive blood culture was then reported to have Bacteroides in it in addition to the Bacillus species.  Patient was observed another day without fever, leukocytosis, or symptoms.  Three other companion blood cultures remained sterile.  She was found to have a mild strep UTI, and received several days of oral Keflex and IV Rocephin.  Physical exam, CXR and CT AP did not note a likely source of Bacteroides.  Given that the bottle from which Bacteroides grew was clearly contaminated as evidenced by the Bacillus species and that three other culture bottles were negative, it was decided not to treat the first culture bottle results.  At the patient and her families request she was discharged home.  She did not have any symptoms of COVID warranting treatment."
Age: 101.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Computerised tomogram abdomen normal, Encephalopathy, Exposure to SARS-CoV-2, Malaise
Clinical narrative: Patient with 2 COVID vaccines who admitted with mild COVID symptoms with concerns for bacteremia.  Provider d/c note:  "Well preserved vaccinated 103 year old residing with her daughter who recently was infected with COVID presents with episode of encephalopathy and apparent syncope.  Testing revealed COVID detected but patient appeared well.  Patient released home but then monitoring blood cultures reported positive for Gram positive rods.  Patient admitted for IV antibiotics but patients culture then interpreted as pseudobacteremia due to Bacillus species.  Patient continued to appear well and without complaints, fever, hypoxemia or pain and was slated to be discharged home but the positive blood culture was then reported to have Bacteroides in it in addition to the Bacillus species.  Patient was observed another day without fever, leukocytosis, or symptoms.  Three other companion blood cultures remained sterile.  She was found to have a mild strep UTI, and received several days of oral Keflex and IV Rocephin.  Physical exam, CXR and CT AP did not note a likely source of Bacteroides.  Given that the bottle from which Bacteroides grew was clearly contaminated as evidenced by the Bacillus species and that three other culture bottles were negative, it was decided not to treat the first culture bottle results.  At the patient and her families request she was discharged home.  She did not have any symptoms of COVID warranting treatment."
Age: 101.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Streptococcal urinary tract infection, Syncope
Clinical narrative: Patient with 2 COVID vaccines who admitted with mild COVID symptoms with concerns for bacteremia.  Provider d/c note:  "Well preserved vaccinated 103 year old residing with her daughter who recently was infected with COVID presents with episode of encephalopathy and apparent syncope.  Testing revealed COVID detected but patient appeared well.  Patient released home but then monitoring blood cultures reported positive for Gram positive rods.  Patient admitted for IV antibiotics but patients culture then interpreted as pseudobacteremia due to Bacillus species.  Patient continued to appear well and without complaints, fever, hypoxemia or pain and was slated to be discharged home but the positive blood culture was then reported to have Bacteroides in it in addition to the Bacillus species.  Patient was observed another day without fever, leukocytosis, or symptoms.  Three other companion blood cultures remained sterile.  She was found to have a mild strep UTI, and received several days of oral Keflex and IV Rocephin.  Physical exam, CXR and CT AP did not note a likely source of Bacteroides.  Given that the bottle from which Bacteroides grew was clearly contaminated as evidenced by the Bacillus species and that three other culture bottles were negative, it was decided not to treat the first culture bottle results.  At the patient and her families request she was discharged home.  She did not have any symptoms of COVID warranting treatment."
Age: 59.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 12 patients vaccinated with Pfizer lot FF8841 beyond best use date
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after BUD
Age: 40.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 3 patients were vaccinated with Pfizer lot FF8841 beyond best use date
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 2.0
Sex: M
Vaccine: RAB
Symptoms: Product administered at inappropriate site
Clinical narrative: Patient received RabAvert day 3 injection in the left gluteus instead of the deltoid. The manufacturer for RabAvert recommends administration into the deltoid for adults or the anterolateral zone of the thigh for infants/small children. The gluteal area should be avoided due to lower neutralizing antibody titers. The agency states that doses administered in the gluteus are not considered valid and must be repeated.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Hypotension, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadedness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Mild, Additional Details: 911 was called and responded to pharmacy. Patient was hypotensive. Patient's husband was called and arrived on scene to transport patient home.
Age: 61.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 6 patients vaccinated with Pfizer lot FF8841 beyond best use date
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: THE BIVALENT HAD BEEN ERRONEOUSLY ADMINISTERED  IN PLACE OF MONOVALENT FOR PRIMARY SERIES
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Angiogram cerebral abnormal, Areflexia, Ataxia, Blood albumin
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture, C-reactive protein, CSF culture, CSF test, Computerised tomogram head normal
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine, Dizziness, Dysarthria, Encephalopathy, Full blood count
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Hyperintensity in brain deep nuclei, Illness, Imaging procedure, Laboratory test normal
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Liver function test, Lumbar puncture normal, Lymphocyte count increased, Macrophage count, Magnetic resonance imaging head abnormal
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging spinal normal, Metabolic function test, Monocyte count, Neurological examination, Neutrophil count
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count increased, Procalcitonin, Pyrexia, Red blood cell sedimentation rate increased, Respiratory symptom
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory syncytial virus infection, Scan with contrast, Slow speech, Somnolence, Urinary tract infection
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis, Vomiting
Clinical narrative: 7 y.o. female with no significant past medical history who presents to the hospital on 9/11/2022 with abnormal gait after recent febrile illness. The abnormal gait was first noticed by parents on evening of 9/8 after an ED visit for recurrent emesis. Dad described it as unsteady and taking wide steps with complaints of dizziness. Since then, the gait stayed the same up until this morning, when he noted some improvement with first 5-6 steps until she is unsteady and wide-based again. Dad stated that Mom also noted her speech has slowed but is non-slurry and understandable and she is able to answer all questions appropriately. No complaints of headache, ear pain, vision changes, diarrhea, vomiting, incontinence, or sensory deficits.    Patient received the 2nd dose of COVID vaccine on 08/20 and developed URI symptoms on 8/22 when she was diagnosed with RSV. Patient was febrile up tp 102-103 on 9/1 and was found to have UTI. She was given Cefdinir and Dad noted that she was very sleepy afterwards. Dizziness and abnormal gait was not seen then. In the ED on 9/11, head CT showed no intracranial pathology    She presents from ED to us on 9/11  with ataxia and dysarthria with areflexia in patellar and achilles reflexes. Labs and imaging so far have been unremarkable, however, per exam findings, this is concerning for early atypical Guillain-Barre Syndrome.    Although she has normal LP and L spine MRI findings however index of suspicion is still high given degree of ataxia (specifically sensory ataxia). Cytoalbuminologic dissociation is not always present especially if early in the disease course. Given speech changes and mild degree of encephalopathy also important to consider GBS variants such as Miller-Fisher variant.    Given her presentation an acute etiology such as stroke (ischemic vs hemorrhagic) and large space occupying tumors were important to rule out. Of note, her MRI brain showed some punctate T2 hyperintensities that seem unrelated to her current presentation. Her MRA of her head did show some possible abnormalities in her posterior circulation however unclear what this represents.
Age: 60.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 31 patients vaccinated with Pfizer lot FF8841 beyond best use date
Age: 1.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, PNC13, VARCEL
Symptoms: Blood test, Electroencephalogram abnormal, Lethargy, Pyrexia, Rash
Clinical narrative: 5/25/22 at 3:30am first witnessed seizure, fever 106 -> parents took private vehicle to Emergency room.  4:00am patient received Tylenol in ER and still lethargic and discharged home.  5:00am patient home.  Motrin given 7:00am, 7:15am second seizure witnessed. 7:45 ambulance arrived and transported patient back to the emergency room.  Patient had another seizure in route to the hospital witnessed by parent.  Patient had fever 104.6 in ER and lethargic.  Patient sent by private vehicle to hospital for an EEG.  Then patient returned back and was observed overnight at ER.  5/26/2022 a rash appeared all over patients abdomen, face, partial down legs.  5/27/2022 another doctor appointment and no fever present.  5/30-31/2022 Rash started to resolve.  Referred to Pediatric neurologist.  Another EEG was preformed.
Age: 1.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, PNC13, VARCEL
Symptoms: Seizure
Clinical narrative: 5/25/22 at 3:30am first witnessed seizure, fever 106 -> parents took private vehicle to Emergency room.  4:00am patient received Tylenol in ER and still lethargic and discharged home.  5:00am patient home.  Motrin given 7:00am, 7:15am second seizure witnessed. 7:45 ambulance arrived and transported patient back to the emergency room.  Patient had another seizure in route to the hospital witnessed by parent.  Patient had fever 104.6 in ER and lethargic.  Patient sent by private vehicle to hospital for an EEG.  Then patient returned back and was observed overnight at ER.  5/26/2022 a rash appeared all over patients abdomen, face, partial down legs.  5/27/2022 another doctor appointment and no fever present.  5/30-31/2022 Rash started to resolve.  Referred to Pediatric neurologist.  Another EEG was preformed.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate increased, Injection site pain, Myalgia
Clinical narrative: Mild headache, increased heart rate, muscle aches, mild fatigue, moderate pain at injection site.
Age: 60.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 26 patients vaccinated with Pfizer lot FF8841 beyond best use date
Age: 4.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Extra dose administered, Wrong patient received product
Clinical narrative: Covid (3rd dose) and Flu 1st dose) were given to the wrong patient. This patient received both of these vaccines on (9/9/22) and were accidentally administered to him again today (9/14/22). Shots were supposed to be administered to patient's brother.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cognitive test, Dementia
Clinical narrative: Dementia began; psych analysis done professionally, experimental early All Rx begun... 2022, January.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after BUD
Age: 79.0
Sex: M
Vaccine: PNC20
Symptoms: CSF protein increased, Guillain-Barre syndrome
Clinical narrative: Developed guillain barre within 6 weeks of administration.
Age: 53.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 12 patients vaccinated with Pfizer lot FF8841 beyond best use date
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain
Clinical narrative: Severe left arm muscle and joint pain. Painful with movement and extension. Some minor aches in all extremities that does not go away unless I take ibuprofen or tylenol.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Hypophagia, Lethargy
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 01/04/2022, LOT #033H21A; pt had a positive COVID test on 2/14/22; lethargic, weakness; found also to have UTI - treated with ABX and IV fluids; supplemental O2 as needed; DNR; poor oral intake
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 01/04/2022, LOT #033H21A; pt had a positive COVID test on 2/14/22; lethargic, weakness; found also to have UTI - treated with ABX and IV fluids; supplemental O2 as needed; DNR; poor oral intake
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient was given 0.25mL Moderna booster vaccine (NDC: 80777-0275-05), which at the time was not approved for <18 yo.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Headache, Injection site pain
Clinical narrative: Body ache, pain at injection site, slight headache, nausea, vomiting, diarrhea, fatigue. Treatment: Rest, Gatorade, no food yet. After initial 12 hours, nausea and vomiting stopped.  Now fatigue , slight headache, muscle soreness and no appetite.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Myalgia, Nausea, Pain, Vomiting
Clinical narrative: Body ache, pain at injection site, slight headache, nausea, vomiting, diarrhea, fatigue. Treatment: Rest, Gatorade, no food yet. After initial 12 hours, nausea and vomiting stopped.  Now fatigue , slight headache, muscle soreness and no appetite.
Age: 21.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 6 patients vaccinated with Pfizer Lot FJ6369 beyond best use date
Age: 55.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 11 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 15.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: THE PFIZER COVID-19 BIVALENT WAS ERRONEOUSLY ADMINISTERED FOR A PRIMARY SERIES
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse events reported. Advised to submit to VAERS due to booster given to bivalent booster. Bivalent booster was not received in pharmacy until 9/7/2022.
Age: 25.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 12 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Chest pain, Cough, Echocardiogram
Clinical narrative: Pt called her PCP for cough and chest pain associated with cough. Her PCP had informed her to go to the ER in view of her symptoms and chest pain. She was tested positive for COVID 19 in the ER and was admitted for further care. She remaind on room air. Not hypoxic. Cough and chest pain has improved significantly. In view of chest pain she had EKG done which was suggestive of A.fib rate controlled with no ST-T changes. Troponin mild elevation likely due to demand ischemia from infection. 2D echo was done.  Her cough has improved and chest pain had resolved she wanted to go home  She stated that since she is not hypoxic and no other on going issues, she insisted on going home. She was not a candidate for steroids or Rx as she is asymptomatic and is on room air.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Myocardial ischaemia, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Pt called her PCP for cough and chest pain associated with cough. Her PCP had informed her to go to the ER in view of her symptoms and chest pain. She was tested positive for COVID 19 in the ER and was admitted for further care. She remaind on room air. Not hypoxic. Cough and chest pain has improved significantly. In view of chest pain she had EKG done which was suggestive of A.fib rate controlled with no ST-T changes. Troponin mild elevation likely due to demand ischemia from infection. 2D echo was done.  Her cough has improved and chest pain had resolved she wanted to go home  She stated that since she is not hypoxic and no other on going issues, she insisted on going home. She was not a candidate for steroids or Rx as she is asymptomatic and is on room air.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse events reported. Advised by DPH to submit to VAERS due to booster given after FDA EUA given to bivalent booster. Bivalent booster was not received in pharmacy until 9/7/2022.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Injection site rash, Injection site reaction, Pain in extremity, Peripheral swelling
Clinical narrative: THE NEXT DAY PATIENTS ARM WAS SWOLLEN PAINFUL RED AND WARM TO THE TOUCH SHE STATED IT LOOKED LIKE SHE HAD A RED RASH AROUND THE INJECTION SITE. RECOMMENDED SHE CALLED HER PRIMARY CARE DOCTOR TO EVALUATE
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash erythematous, Skin warm
Clinical narrative: THE NEXT DAY PATIENTS ARM WAS SWOLLEN PAINFUL RED AND WARM TO THE TOUCH SHE STATED IT LOOKED LIKE SHE HAD A RED RASH AROUND THE INJECTION SITE. RECOMMENDED SHE CALLED HER PRIMARY CARE DOCTOR TO EVALUATE
Age: 76.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 9 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Chest pain, Immediate post-injection reaction, Injection site pain, Palpitations
Clinical narrative: No previous health conditions. Fluarix Quadrivalent was administered in 10/2021 and caused immediate cardiac abnormal palpatations and chest pain once received, which lasted several weeks.  Site of flu injection has caused and is causing severe pain for almost one year now, my arm hurts with dull and sharp pains from the flu shot injection site and has spread to my elbow (has spread approximately 7 inches with constant pain) - this pain is EVERY DAY.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after BUD
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: No adverse events reported. Advised by Agency to submit to VAERS due to booster given after FDA EUA given to bivalent booster. Bivalent booster was not received in pharmacy until 9/8/2022.
Age: 23.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 6 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Adverse reaction, Dehydration, Fatigue, Feeling abnormal, Influenza like illness
Clinical narrative: Upon leaving the appointment, my daughter expressed that she could ?feel it going through her body?. Within a an hour or so she was feeling tired, sluggish and pain in the shot site and aches throughout her body by mid afternoon.   Couldn?t control the body aches and pain through day/night. Fever present. (Flu-like symptoms)
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Injection site pain, Laboratory test, Pain, Pyrexia, Sluggishness
Clinical narrative: Upon leaving the appointment, my daughter expressed that she could ?feel it going through her body?. Within a an hour or so she was feeling tired, sluggish and pain in the shot site and aches throughout her body by mid afternoon.   Couldn?t control the body aches and pain through day/night. Fever present. (Flu-like symptoms)
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Streptococcal infection, Streptococcus test positive
Clinical narrative: Upon leaving the appointment, my daughter expressed that she could ?feel it going through her body?. Within a an hour or so she was feeling tired, sluggish and pain in the shot site and aches throughout her body by mid afternoon.   Couldn?t control the body aches and pain through day/night. Fever present. (Flu-like symptoms)
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Injection site haemorrhage, Injection site swelling
Clinical narrative: After administering the vaccine, the patient's arm started to bleed. After wiping the site with alcohol swabs twice, the site of reaction started to swell. The swelling was about 1 inch in diameter and raised half an inch. After talking to patient, this was the his first time getting this reaction. He had previously only had the Moderna vaccine and this was his first time getting Pfizer. The swelling started to dissipate over the course of 10 minutes while we were observing the patient.
Age: 24.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Vaccination error
Clinical narrative: Did not appreciate visible wheal. Dose repeated with new vial  and wheal visualized.
Age: 16.0
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Product administered to patient of inappropriate age, Product administration error
Clinical narrative: no adverse effect was given Shingrix in error
Age: 63.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 9 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: 1/16/22 Our records show patient had a positive COVID test at local Community Hospital; patient passed away in the hospital.
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient presented to the pharmacy to receive the second dose in her primary vaccine series. Patient was given a Pfizer Bivalent Booster shot in lieu of the Pfizer Monovalent Booster that should have been administered due to the fact that she had not completed her primary series.
Age: 64.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 6 patients vaccinated with Pfizer lot FJ6369 beyond best use date
Age: 16.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient had series of HPV9 vaccine July 2017 and June 2019 Patient was only to get Meningococcal vaccine, was accidently given HPV9
Age: 64.0
Sex: U
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: 5 patients vaccinated with Pfizer lot FJ6369
Age: 71.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 4 patients vaccinated with Pfizer lot FP4554 beyond best use date
Age: 90.0
Sex: U
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: 2 patients vaccinated with Pfizer lot FP4554 beyond best use date
Age: 1.83
Sex: M
Vaccine: DTPPVHBHPB
Symptoms: Injection site bruising, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 5/17/2022 patient developed a softball size redness, bruising, swelling and heat from injection site.  5/18/2022 Patients redness continued and progressed to be a bit bigger in size, redness, and bruising still present.  5/19/2022 Patient parents took child in to hospital to be evaluated.  Antibiotics where prescribed, but not taken.  5/28/22 redness, swelling, heat, and bruising resolved.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, SARS-CoV-2 test positive
Clinical narrative: Pt in a SNF; pt had a positive COVID test in the facility on 1/24/22; treated with 10 days of ABX for COVID pneumonia; pt passed away in the facility
Sex: U
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Adminstiration Error. It was caught when new Bivalent Moderna Vaccines were received Tuesday Septmeber 13, 2022. The nurse that was putting up the vaccines realized that on Monday September 12, 2022 when she had to move moderna vaccines from freezer to fridge to thaw to be given that she had moved and given Monovalent Moderna ages 6yrs-11 yrs (booster) instead of Bivalent Moderna Booster. Distrct Immunization Coordinator was let known of incident and proceeded to give directions about next steps. All 18 patietns were identified that received the Monovalent Moderna and was let known of what happened and that they were allowed per CDC to receive a Bivalent booster in 2 months from last dose which was 09-12-2022. Incident Report was written up and VAERS completed.
Age: 44.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Fatigue, Pain
Clinical narrative: patient requested Boostrix, but Shingrix was administered chills, body aches, fatigue, shoulder pain that lasted several days
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Anion gap, Anticoagulant therapy, Asthenia
Clinical narrative: Patient is a 66-year-old male With history of colon cancer with metastasis to the liver and recent COVID diagnosis on August 31 presenting to the emergency department via EMS from home for increased shortness of breath and generalized weakness.  Patient was seen at facility on Sunday for cough with his COVID, he was given azithromycin to go home with.  Family states ever since then he has been declining at home.  He has been very weak and unable to get out of bed much.  He is normally alert and oriented x4 and active, however today family had a hard time even getting him off the couch and noticed he seemed to be breathing fast so they called 911.  Per EMS, patient was 90% on room air at his home, and he was tachypneic.  They gave a DuoNeb breathing treatment in route along with Solu-Medrol 125 mg IV.  Patient states he feels very fatigued and generally weak, he denies any chest pain, abdominal pain, nausea, vomiting or diarrhea.  His last chemotherapy dose was 2 weeks ago, he is scheduled to have another 1 tomorrow, however this will be canceled. Associated Symptoms: cough, fatigue, shortness of breath, weakness
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood creatinine increased, Blood culture, Blood lactic acid, Blood test
Clinical narrative: Patient is a 66-year-old male With history of colon cancer with metastasis to the liver and recent COVID diagnosis on August 31 presenting to the emergency department via EMS from home for increased shortness of breath and generalized weakness.  Patient was seen at facility on Sunday for cough with his COVID, he was given azithromycin to go home with.  Family states ever since then he has been declining at home.  He has been very weak and unable to get out of bed much.  He is normally alert and oriented x4 and active, however today family had a hard time even getting him off the couch and noticed he seemed to be breathing fast so they called 911.  Per EMS, patient was 90% on room air at his home, and he was tachypneic.  They gave a DuoNeb breathing treatment in route along with Solu-Medrol 125 mg IV.  Patient states he feels very fatigued and generally weak, he denies any chest pain, abdominal pain, nausea, vomiting or diarrhea.  His last chemotherapy dose was 2 weeks ago, he is scheduled to have another 1 tomorrow, however this will be canceled. Associated Symptoms: cough, fatigue, shortness of breath, weakness